Additionally, we verified that SNHG5 enhances the expression of E2F3 by competitively binding to miR-205 and that the effect of si-SNHG5 on glioma cells could be impaired by the miR-205 inhibitor. The gene discussed is E2F3; the disease is central nervous system cancer.